Schedule 8 and Declared Schedule 4 Medicines Management Policy
|
|
- Josephine Reeves
- 8 years ago
- Views:
Transcription
1 Department of Health and Human Services SYSTEM PURCHASING AND PERFORMANCE - MEDICATION STRATEGY AND REFORM Schedule 8 and Declared Schedule 4 Medicines Management Policy SDMS Id Number: Effective From: June 2014 Replaces Doc. No: Custodian and Review Responsibility: Contact: Applies to: Policy Type: Policy ID (as assigned by Corporate Document and Information Services) Document title and number Medication Strategy and Reform Director, Medication Strategy and Reform THO-North, THO-South, THO-North West DHHS Wide Policy Review Date: April 2015 Keywords: Routine Disclosure: Approval Schedule 8, S8, Schedule 4 Declared, S4D, Medication, Safety, Prescribing, Yes Prepared by Sulfi Newbold Medicines Policy Officer May 2014 Through Through Cleared by Anita Thomas Senior Specialist Pharmacist Quality Use of Medicine THO-N Medication Management and Safety Committee THO-NW Medication Safety & Improvement Committee THO-S Quality Use of Medicine Committee John Kirwan Karen Linegar Matthew Daly THO-N Chief Executive Officer THO-NW Acting Chief Executive Officer THO-S Acting Chief Executive Officer May May June June June 2014 Revision History Version Approved by name Approved by title Amendment notes Name Name Name Position Title Position Title Position Title This Policy may be varied, withdrawn or replaced at any time. Compliance with this directive is mandatory for the Department of Health and Human Services. PLEASE DESTROY PRINTED COPIES. The electronic version of this Policy is the approved and current version and is located on the Department of Health and Human Services Strategic Document Management System. Any printed version is uncontrolled and therefore not current. Page 1 of 9
2 Purpose The purpose of this policy is to provide safe and legally compliant practices for the storage, documentation, prescribing, administration and destruction of Schedule 8 and Declared Schedule 4 Restricted Substances (S8 and S4D medicines) in Tasmanian public health services. This policy should be used to inform locally developed procedures, specific to each health service, pertaining to the safe and appropriate management of S8 and S4D medicines. The control and use of S8 and S4D medicines must be in accordance with the Poisons Act 1971 and the Poisons Regulations 2008, and satisfy the National Safety and Quality Health Service Standard 4 in Medication Safety. Mandatory Requirements Definitions: S8 and S4D Medicines: Medicines that are listed in the Poisons Act as Schedule 8 or Declared Schedule 4 Restricted Substances, and are controlled by law due to the high-risk of addiction, misuse or diversion. Health Service: Any Tasmanian public health service or facility that is authorised to store and administer medicine. This includes major Tasmanian acute care public hospitals, other public inpatient facilities, rural health facilities, and community health services. Acute Hospitals: This refers to Royal Hobart Hospital, Launceston General Hospital, North West Regional Hospital, and Mersey Community Hospital. Due to the increased volume of patients, visitors, staff, and medicine quantities in these facilities, there is also an increased risk of error or diversion of S8 and S4D medications. Therefore, in acute hospitals, where there is an increased availability of staff and other resources, extra safety controls are imposed by this policy (over and above Tasmanian legislative requirements) in the interests of patient, staff and visitor safety. Pharmacy: The Pharmacy Department of acute hospitals within each Tasmanian Health Organisation, or the Pharmacy dispensary, where applicable, of other health services. Patient Treatment Areas: This includes wards, clinics, and procedure rooms, or patients homes when visited by community health nurses. Opened/Part Dose: Part of a tablet; a quantity of medicine within an open ampoule or vial; medicine that has been prepared for a patient that has subsequently been refused; or medicine that has been mishandled in such a way that renders the medicine unfit for consumption. Unopened/Sealed Medicine: Any medicine that is contained safely within a blister-pack, ampoule, vial, flask, bag, or bottle, or any other original packaging. Authorised Persons: Please refer to the Roles and Responsibilities/Delegates section of this policy. Patients Own Medication (POMs): Medication that is owned by the patient. In health services where variations of practice exist due to staffing and/or resource constraints, local procedures that are specific to the requirements of that health service must be both legally compliant and documented as a detailed protocol. This Policy may be varied, withdrawn or replaced at any time. Compliance with this directive is mandatory for the Department of Health and Human Services. PLEASE DESTROY PRINTED COPIES. The electronic version of this Policy is the approved and current version and is located on the Department of Health and Human Services Strategic Document Management System. Any printed version is uncontrolled and therefore not current. Page 2 of 9
3 Storage of S8 and S4D Medicines: In Pharmacy and patient treatment areas of all health services, S8 medicines must be stored in a cupboard or receptacle (a safe ) that meets the requirements of the Poisons Regulations In Pharmacy of all health services, S4D medicines must be in a secure area and not accessible to the public or unauthorised staff. In patient treatment areas of all health services, S4D medicines must be stored in a cupboard or receptacle (a safe ) that meets the requirements of the Poisons Regulations Installation of a new S8 safe or relocation of an existing safe must be done so in consultation with the relevant Pharmacy Site Manager within the Tasmanian Health Organisation (THO). In all health services, the S8 and S4D medicines safes must not be left unsecured if unattended. In all acute hospitals, and wherever possible in other health services, two persons authorised to handle S8 and S4D medicines, as defined in the Roles and Responsibilities/Delegates section of this policy, must be present whenever an S8 or S4D medicines safe is open. In all acute hospitals, only one key should exist for any S8 or S4D medicines safe that requires a key for access. Further instruction for the management of the S8 or S4D safe key should be detailed in a locally developed procedure. A swipe-card, pin code, or other method of security, may be considered an appropriate alternative to a key-locked S8 or S4D medicines safe. A swipe-card, a pin code, or any other security measure that protects access to any S8 or S4D medicines safe, is not transferrable between staff. The maintenance of such security is the responsibility of the manager of the area. (*Refer to Roles and Responsibilities/Delegations) In all other health services, the management of the S8 or S4D medicines safe, and all associated security measures, should be detailed in a locally developed protocol. Documentation of S8 and S4D Medicines All transactions involving S8 medicines must be accurately recorded in a dedicated register in accordance with legislative requirements. In all patient treatment areas of all health services, all transactions involving S4D medicines must be accurately recorded in a dedicated register in the same manner as S8 medicines. Patient treatment areas of health services that administer S8 or S4D medicines from a Dose Administration Aid (DAA) should have a documented procedure for recording such administration. All transactions involving S8 and/or S4D medicines, including but not limited to, acquisition of S8 and/or S4D medicines from Pharmacy, transfer of S8 and/or S4D medicines between patient treatment areas, and return of S8 and/or S4D medicines to Pharmacy, must be accompanied by appropriate paperwork such as to create an audit trail. In all acute hospitals, and wherever possible in other health services, all transactions (such as acquisition, transfers between wards, return to Pharmacy, or disposal) involving S8 and S4D medicines must be double-checked and double-signed by staff who are authorised to do This Policy may be varied, withdrawn or replaced at any time. Compliance with this directive is mandatory for the Department of Health and Human Services. PLEASE DESTROY PRINTED COPIES. The electronic version of this Policy is the approved and current version and is located on the Department of Health and Human Services Strategic Document Management System. Any printed version is uncontrolled and therefore not current. Page 3 of 9
4 so (i.e. Two authorised signatures must be recorded for all S8 and S4D medicine transactions in the appropriate S8 or S4D Register, and on any other relevant documentation.) In all acute hospitals, and wherever possible in other health services, the S8 and S4D Registers must be checked regularly by two persons authorised to handle S8 and S4D medicines, as defined in the Roles and Responsibilities/Delegates section of this policy, to ensure the quantity of medication in the safe is equal to the quantity of medication recorded in the Registers. Any discrepancies must be reported immediately to the nurse or pharmacist in charge, and also reported as an incident via the agency s approved incident reporting system (Safety Reporting and Learning System (SRLS)), as soon as is practicable. Definitions of persons authorised to act as signatory to S8 and S4D medicine administration and/or other transactions are outlined in the Roles and Responsibilities/Delegates section of this policy. See also Administration of S8 and S4D Medicines of this policy. See also Destruction of S8 and S4D Medicines of this policy. For instruction on the documentation of BENZODIAZAPINE administration refer to Best Practice Addendum BENZODIAZAPINE ADMINISTRATION and DOCUMENTATION of this policy. Prescribing S8 and S4D Medicines S8 and S4D medicines must only be prescribed in a health service by: o A registered medical practitioner, in accordance with Tasmanian legislation. o A registered nurse practitioner, in accordance with Tasmanian legislation. o A registered dental practitioner, in accordance with Tasmanian legislation. o A registered eligible midwife who is also schedule medicine endorsed, in accordance with Tasmanian legislation. Prescriptions for S8 medicines must be correctly written, contain all necessary information, and include both the prescriber s signature and the medicine order written in the prescriber s own hand writing, in accordance with Tasmanian legislation. Electronic prescriptions for S8 or S4D medicines must be consistent with legislative requirements. A discharge or outpatient prescription for an S8 medicine must only include ONE item: o Other medicines required for the same patient, at the same time as an S8 medicine, must be written appropriately as a separate prescription. o If multiple S8 medicines are required for the same patient, at the same time, a separate prescription must be written for each S8 medicine. An inpatient order for an S8 or S4D medicine should be written on the National Inpatient Medication Chart (NIMC), or approved ancillary chart, in accordance with SPP-MSR: The use of the National Inpatient Medication Chart Policy. Prescriptions must be written in such a way to deter fraudulent amendments being made (e.g. marking a line through blank sections of the prescription page.) Page 4 of 9
5 When dispensing S8 or S4D medicines for outpatient or discharge supply, the prescriber s name must be accurately recorded in the Pharmacy dispensing system. For further information, refer to SPP-MSR: Authority to Prescribe Medications Policy. Administration of S8 and S4D Medicines In all health services, only persons authorised to do so may administer S8 or S4D medicines, in accordance with Tasmanian legislation. In all acute hospitals, to ensure patient safety and staff protection, the administration of S8 medicines must be witnessed and co-signed on the medication order by a second person authorised to do so, as defined in the Roles and Responsibilities/Delegates section of this policy (i.e. TWO authorised signatures must be present on the National Inpatient Medication Chart (NIMC) or other approved ancillary chart.) This practice should also occur wherever possible at other health services. At least one of the authorised persons to have signed S8 or S4D medicine out of the Register must also administer the medicine to the patient. In health services where a witness is not available for S8 administration, a note must be made on the medication order and/or in the S8 Register stating that no witness was available. For instruction on the documentation of BENZODIAZAPINE administration refer to Best Practice Addendum BENZODIAZEPINE ADMINISTRATION and DOCUMENTATION of this policy. Health services may consider the implementation of co-signing of medication orders for S4D medicine (other than BENZODIAZEPINE) administration (see dot point above) at their discretion. Local protocols should detail such requirements. Anaesthetics: S8 medicines handed over to the possession of an anaesthetist must be signed for by the anaesthetist. The anaesthetic record must be signed by the anaesthetist and placed in the patient history. A counter-signature for this administration is not required. Destruction of S8 and S4D Medicines Disposal methods of S8 medicines must meet legislative requirements and SPP-MSR: Management and Disposal of Unwanted Medicines Policy. S8 and S4D medicines must not be placed in general waste containers or sharps containers. Any spillage, breakage or unintentional destruction of an S8 or S4D medication must be recorded in the appropriate Register, reported immediately to the nurse or pharmacist in charge, and reported as an incident via the approved incident reporting system, as soon as is practicable. Opened/Part Doses In patient treatment areas, any opened/part dose of S8 or S4D medicine, including but not limited to syringe or infusion flasks, vials, or oral preparations, should be rendered unusable and discarded immediately, prior to, or on the cessation of administration to the patient. Page 5 of 9
6 In acute hospitals, and wherever else possible, the disposal of opened/part doses or unsealed containers of S8 and S4D medicines must be executed and witnessed by two authorised persons*, documented in the appropriate Register, and signed by both persons. (*See Roles and Responsibilities/Delegations). In community or remote health services, if a witness is not available to confirm and co-sign the S8 Register for a discarded open/part dose of S8 medicine, a note must be made on the medication order and/or S8 Register stating no witness was available. Unopened/Sealed Medicines In all acute hospitals, all unopened/sealed unwanted or expired S8 or S4D medicines must be sent to Pharmacy from patient treatment areas with appropriate documentation, as determined by local procedures, so as to create an audit trail. Destruction of S8 medicines in Pharmacy may only be performed by: o Two registered Pharmacists, or o One registered Pharmacist and ONE other Pharmacy staff member who has been approved as an authorised person by the DHHS Pharmaceutical Services Branch, in accordance with Tasmanian legislation. Such individual approval is to be sought by the Pharmacy Site Manager. For all health services outside the acute hospitals, in the interest of patient, staff and environmental safety, Pharmacy in each THO is the preferred centralised service for the management and disposal of all unopened/sealed S8 and S4D medicine that is unwanted or expired. Arrangements should be made in consultation with the Pharmacy Site Manager. Health services that do not have Pharmacy on site, and are unable to access secure transport to the THO Pharmacy, must manage the destruction of unopened/sealed S8 medicines in accordance with Tasmanian legislation. In these services, S8 medicines that have expired or are no longer required must be destroyed by TWO authorised persons, as defined in Roles and Responsibilities/Delegations. Unwanted S8 and S4D POMs may be disposed of by community health service staff (when requested by the patient to whom the medication belongs), or by the patients themselves, via disposal services available through community pharmacies. This disposal service is only appropriate for unwanted POMs (i.e. THO owned S8 and S4D medicine stock must not be disposed of via disposal services intended for community use only). All destruction of unopened/sealed S8 medicines must be accurately recorded in an approved Register which must be witnessed and signed by both authorised persons, as defined above. Possession of S8 and S4D Medicines Persons authorised to handle S8 and S4D medicines, may have them in their possession when appropriate to their work duties, and within their scope of practice. Transit of S8 and S4D medicines must be as direct as practicable. Detours or breaks should not be taken by staff who are in possession of, and responsible for, S8 and S4D medicines. Health service staff who are authorised under Section 25a of the Poisons Act to be in possession of and transport S8 and S4D medicines must maintain an appropriate audit trail from the medication collection point to the destination. There is to be no intermediary in this delivery process, with one registered nurse required for the entire journey. Page 6 of 9
7 Roles and Responsibilities/Delegations Authorised Persons for S8 and S4D medicines handling, administration, destruction of part doses of S8 and S4D medicines in patient treatment areas, and destruction of expired/unwanted S8 medicines (in health services where return to Pharmacy is not possible): Registered Nurses and Midwives Registered Nurse Practitioners Registered Medical Practitioners Registered Dental Practitioners Registered Ambulance Officers Medication Endorsed Enrolled Nurses (ME EN) o ME EN must be working under the direct supervision of another authorised person (listed above), and practicing in accordance with the DHHS: Enrolled Nurse Scope of Practice Medication Administration and Intravenous Fluid Management Policy (link) Authorised Persons for S8 and S4D medicines handling and destruction, but NOT administration (except in the circumstances of opioid dependence programs and other daily dosing programs as authorised by a registered medical practitioner), in accordance with Tasmanian legislation: Registered Pharmacists Approved Second Persons for S8 and S4D medicines administration ONLY: In health services that cannot provide a second authorised person to act as witness for the administration of an S8 or S4D medicine (as defined above) due to staffing constraints, a responsible second person may be nominated to act in this capacity. The following roles are approved second persons under such circumstances: o o Non Medication Endorsed Enrolled Nurse Health Care Assistant Any other nomination of an approved second person (as defined above) must be made by the nurse in charge, and detailed in a locally developed protocol. Approved Second Persons for S8 and S4D medicines handling but NOT administration or destruction: Pharmacy staff members who have been approved by the Pharmacy Site Manager to handle but not administer or destroy S8 and S4D medicines, within their scope of practice, while working under the direct supervision of an authorised person. Details of such approval must be clearly stated in a locally developed protocol. NB: An Approved Second Person is NOT approved to act as witness for the destruction of S8 medicines unless specifically authorised to do so by the DHHS Pharmaceutical Services Branch, as outlined in Destruction of S8 Medicines of this document. It is the responsibility of all registered medical practitioners, nurse practitioners, and dental practitioners involved in the supply of S8 and S4D medicines to remain current and compliant with Tasmanian legislation pertaining to the prescribing of S8 and S4D medicines. Page 7 of 9
8 In patient treatment areas, the key (or other right of access) to the S8 or S4D medicines safe is the responsibility of the nurse in charge, or another authorised person, as delegated by the nurse in charge. In Pharmacy, the key (or other right of access) to the S8 safe is the responsibility of the Pharmacy Site Manager, or a delegate as authorised by the Pharmacy Site Manager, such as the Dispensary Manager or oncall pharmacist. It is the responsibility of Pharmacy Managers and Nurse Managers to ensure all patient treatment and support staffs comply with the requirements of this policy at all times. It is the responsibility of all staff involved in the handling of S8 and S4D medicines to uphold the mandatory requirements of this policy to ensure the safe and legally compliant management of these medicines. Risk Implications S8 and some S4D medicines are often identified as being addictive in nature and have a high potential for abuse. In addition, narcotics and sedative agents are also identified as being high-risk medications with which error or misadventure is more likely to result in devastating outcomes, as outlined in SPP-MSR: High Risk Medication Management Policy. Measures taken for the control of these medicines in Tasmanian health services, as outlined by this policy, are imposed to ensure patient safety, maximum staff accountability, and to avoid access to medicines for abuse and illegal commerce. Failure to comply with this policy, without providing a good reason for doing so, may lead to disciplinary action. This is a state-wide policy and must not be re-interpreted so that subordinate policies exist. Should discreet operational differences exist, these should be expressed in the form of an operating procedure or protocol. Training All sites must provide adequate training to staff to ensure: All staff members involved with the management of S8 and S4D medicines are trained in identifying S8 and S4D medicines. All staff members involved with the management of S8 and S4D medicines are familiar and compliant with this statewide policy. All staff members involved with the management of S8 and S4D medicines are familiar and compliant with local protocols for the safe and legally compliant handling of S8 and S4D medicines. Audit All S8 and S4D Registers, and all documentation associated with ordering, transferring, and the destruction of S8 and S4D medicines, must be held for a minimum period of TWO years and made available for audit by external governance, such as the DHHS Pharmaceutical Services Branch, as required. Page 8 of 9
9 All such evidence of S8 and S4D medicines transactions must also be audited regularly and frequently by Pharmacy and Nurse Managers or delegates, in accordance with local protocols and legislative requirements. Any deviation from this policy is considered to be a reportable incident and should be documented in the approved incident reporting system, as per DHHS policy. Attachments 1. Best Practice Addendum Benzodiazepine Administration and Documentation 2. DHHS: Enrolled Nurse Scope of Practice - Medication Administration and Intravenous Fluid Management Policy 3. DHHS: Incident Reporting and Management Policy 4. SPP-MSR: High-Risk Medication Management Policy 5. SPP-MSR: Storage of Medicines Policy 6. SPP-MSR: The use of the National Inpatient Medication Chart Policy 7. SPP-MSR: Management and Disposal of Unwanted Medicines Policy 8. SPP-MSR: High Risk Medication Management Policy 9. SPP-MSR: Authority to Prescribe Medications Policy. 10. Poisons Act Poisons Regulations 2008 Best Practice Addendum Benzodiazepine Administration and Documentation In acute hospitals and wherever possible in other health services, to ensure patient safety and staff protection, the administration of BENZODIAZAPINE medicines must be witnessed and cosigned on the medication order by a second person authorised to do so, as defined in the Roles and Responsibilities/Delegates section of this policy (i.e. TWO authorised signatures must be present on the National Inpatient Medication Chart (NIMC) or other approved ancillary chart.) This practice should also occur wherever possible at all other health services. This Best Practice Addendum is mandatory in Tasmanian Health Organisation South (THO-S) and Tasmanian Health Organisation North-West (THO-NW), and wherever practicable in Tasmanian Health Organisation North (THO-N). Page 9 of 9
Preparation and Handling of Cytotoxic, Hazardous and Potentially Hazardous Medicines Policy
Department of Health and Human Services SYSTEM PURCHASING AND PERFORMANCE - MEDICATION STRATEGY AND REFORM Preparation and Handling of Cytotoxic, Hazardous and Potentially Hazardous Medicines Policy SDMS
More informationMedication Management Guidelines for Nurses and Midwives
Medication Management Guidelines for Nurses and Midwives 1. Introduction As the statutory body responsible for the regulation of nursing and midwifery practice in Western Australia (WA), the Nurses & Midwives
More informationGovernance of Controlled Drugs using Automated Cabinet-based Stock-control Systems
T: 0870 4328 250 F: 0870 4328 251 E: info@avantec.uk.com W: www.avantec.uk.com Governance of Controlled Drugs using Automated Cabinet-based Stock-control Systems An evaluation of ward practice and how
More informationNHS Professionals. Guidelines for the Administration of Medicines
NHS Professionals Guidelines for the Administration of Medicines Introduction The control of medicines in the United Kingdom is primarily through the Medicines Act (1968) and associated British and European
More informationPolicy for the Storage and Administration of Medication in Custody Suites
Not Protectively Marked Policy for the Storage and Administration of Medication in Custody Suites Policy Reference No. P22:2000 Portfolio Holder Assistant Chief Constable Policy Owner Superintendent Donnell
More informationPolicies and Procedures. Number: 1127
Policies and Procedures Title: NARCOTIC CONTROL: DOCUMENTATION AND COUNT Authorization: [X] Pharmacy/Nursing Committee [X] SHR Nursing Practice Committee Number: 1127 Source: Pharmacy/Nursing Cross Index:
More informationStandard Operating Procedure
Standard Operating Procedure Title: Controlled Drugs in Community Services (including Community Hospitals, Community Nursing and Community Units) Prepared by: Rajitha Ramakrishnan Presented to: Care &
More informationMULTI AGENCY POLICY FOR THE ADMINISTRATION OF MEDICATION AND HEALTH CARE PROCEDURES:
MULTI AGENCY POLICY FOR THE ADMINISTRATION OF MEDICATION AND HEALTH CARE PROCEDURES: Early years provision, Educational Establishments and Voluntary Services Document reference number: C O R P O L O 0
More informationControlled Drugs in Perioperative Care
Controlled Drugs in Perioperative Care 2006 Published by The Association of Anaesthetists of Great Britain and Ireland, 21 Portland Place, London W1B 1PY Telephone: 020 7631 1650, Fax: 020 7631 4352 E-mail:
More informationIntroduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6
Index Index Section Page Introduction 2 1. The Role of Pharmacy Within a NHS Trust 3 2. Pharmacy Staff 4 3. Pharmacy Facilities 5 4. Pharmacy and Resources 6 5. Prescription Charges 7 6. Communication
More informationNARCOTIC AND CONTROLLED DRUG MANAGEMENT
NARCOTIC AND CONTROLLED DRUG MANAGEMENT LHSC Policy available on the intranet at: http://appserver.lhsc.on.ca/policy/search_res.php? polid=pcc019&live=1 STAFF ADMINISTERING NARCOTICS: Manage area drug
More informationNHS Lanarkshire Care Homes Protocol Group. Care Home Prescriptions - Good Practice Guide
NHS Lanarkshire Care Homes Protocol Group Care Home Prescriptions - Good Practice Guide Date of Publication Review Date August 2015 Responsible Author Francesca Aaen Care Homes Pharmacist on behalf of
More informationGUIDELINES FOR THE CONTROL AND ADMINISTRATION OF MEDICINES DOMICILIARY CARE AGENCIES
GUIDELINES FOR THE CONTROL AND ADMINISTRATION OF MEDICINES DOMICILIARY CARE AGENCIES January 2009 Contents Page Number 1.0 Introduction 3 2.0 Background 4 3.0 Criteria 5 3.1 Referral 5 3.2 Levels of assistance/consent
More informationDate Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication
POLICY SOMERSET COUNTY BOARD OF EDUCATION 1. PURPOSE Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication Number: 600-32 Date
More informationStandard Operating Procedure for Management of Controlled Drugs within Louth Urgent Care Centre
Standard Operating Procedure for Management of Controlled Drugs within Louth Urgent Care Centre Reference No: Version: 1.0 Ratified by: G_CS_61 LCHS Trust Board Date ratified: 28 th April 2015 Name of
More informationFile No.: 20100701. Guidelines for the Administration of certain substances by aged-care workers in residential aged care services
File No.: 20100701 Guidelines for the Administration of certain substances by aged-care workers in residential aged care services 1 September 2010 Contents 1. Introduction...4 2. Regulation 95EA...5 3.
More informationCONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION
CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed
More informationPurpose... 2. What s new?... 2. Role of pharmacists and pharmacy technicians in physician-assisted death... 3
Table of Contents Purpose... 2 What s new?... 2 Role of pharmacists and pharmacy technicians in physician-assisted death... 3 Complying with ACP s Standards of Practice for Pharmacists and Pharmacy Technicians...
More informationGood Practice Guidance: The safe management of controlled drugs in care homes
Good Practice Guidance: The safe management of controlled drugs in care homes Medicines Management Social Care Support Team Reviewed April 2015 Good Practice Guidance: The safe management of controlled
More informationPharmacy Apprenticeships
Pharmacy Apprenticeships JOB TITLE: BAND: BASE: Pharmacy Technician Pharmacy Department Pharmacy Assistant Pharmacy Department Apprentice Leicester Royal Infirmary Leicester General Hospital Glenfield
More informationUW School of Dentistry Comprehensive Medication Policy
UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides
More informationPatient Group Directions. Guidance and information for nurses
Patient Group Directions Guidance and information for nurses Patient Group Directions Guidance and information for nurses Contents Introduction 4 What is a patient group direction (PGD)? 4 When can PGDs
More informationMASSACHUSETTS. Downloaded January 2011
MASSACHUSETTS Downloaded January 2011 150.007 NURSING SERVICES (G) Nursing and Supportive Routines and Practices. (2) No medication, treatment or therapeutic diet shall be administered to a patient or
More informationNurse Practitioners in NSW
Policy Directive Document Number PD2012_026 Publication date 15-May-2012 Nurse Practitioners in NSW Ministry of Health, NSW 73 Miller Street North Sydney NSW 2060 Locked Mail Bag 961 North Sydney NSW 2059
More informationGuidelines on endorsement as a nurse practitioner
Guidelines on endorsement as a nurse practitioner 7160 Introduction The National Registration and Accreditation Scheme (the National Scheme) for health professionals in Australia commenced on 1 July 2010
More informationDocument Title: Supply of Clinical Trials Investigational Material: Dispensing, Returns and Accountability
Document Title: Supply of Clinical Trials Investigational Material: Document Number: SOP072 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G
More informationSecretary Approval Cardiac Arrest frequently asked questions
Secretary Approval Cardiac Arrest frequently asked questions Secretary Approval Cardiac Arrest - frequently asked questions 1. What is a Secretary approval? Some regulations within the Drugs, Poisons and
More informationIAC 10/5/11 Pharmacy[657] Ch 40, p.1 CHAPTER 40 TECH-CHECK-TECH PROGRAMS
IAC 10/5/11 Pharmacy[657] Ch 40, p.1 CHAPTER 40 TECH-CHECK-TECH PROGRAMS 657 40.1(155A) Purpose and scope. The board may authorize a hospital pharmacy to participate in a tech-check-tech program. The board
More informationInvestigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
More informationNurse Practitioner Frequently Asked Questions
HEALTH SERVICES Nurse Practitioner Frequently Asked Questions The Frequently Asked Questions (FAQs) have been designed to increase awareness and understanding of the Nurse Practitioner role within the
More informationUTCVM PHARMACY STANDARD OPERATING PROCEDURES
UTCVM PHARMACY STANDARD OPERATING PROCEDURES Updated: 4/5/2004 I. General Procedures A. Hours: The Pharmacy will be open Monday through Friday, 8:00AM to 6:00PM; Saturday 8:00AM to 1:00PM. The Pharmacy
More informationDisposal of Pharmaceuticals, and their empty containers, in the Workplace
Disposal of Pharmaceuticals, and their empty containers, in the Workplace Prepared by Bio-Team Mobile LLC There is a lot of misinformation being circulated about disposal of pharmaceuticals ever since
More informationARKANSAS. Downloaded January 2011
ARKANSAS Downloaded January 2011 302 GENERAL ADMINISTRATION 302.11 Pharmacies operated in nursing homes shall be operated in compliance with Arkansas laws and shall be subject to inspection by personnel
More informationabcdefghijklmnopqrstu
Primary and Community Care Directorate Pharmacy Division Dear Colleague SAFER MANAGEMENT OF CONTROLLED DRUGS: A Guide to Good Practice in Secondary Care (Scotland) Action NHS Boards are asked to copy this
More informationGuidelines for dispensing of medicines 6585 08/10
for dispensing of medicines 6585 08/10 for dispensing of medicines Contents Introduction 1 Who needs to use these guidelines? 1 Summary of guidelines 1 1 1 Dispensing precaution safety of prescriptions
More informationROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
More informationJOB DESCRIPTION. JOB TITLE: Lead Pharmacy Technician-Grade 4. The Portland Hospital for Women and Children
JOB DESCRIPTION JOB TITLE: Lead Pharmacy Technician-Grade 4 CLINICAL UNIT: BASE: MANAGED BY: ACCOUNTABLE TO: Pharmacy The Portland Hospital for Women and Children Pharmacy Manager Pharmacy Manager HOSPITAL
More informationRoles and Responsibilities Policy
Roles and Responsibilities Policy Contents Policy... 2 Scope/Audience... 2 Associated Documents... 2 Definitions... 2 Accountability... 2 Scope of Practice Statement:... 2 Anaesthetic Technicians... 3
More informationManagement of Pupils with Health Care Needs in Schools Policy
Management of Pupils with Health Care Needs in Schools Policy Date: January 2013 Version number: 1 Author: Sheila Fraser, PHN Development Manager Review date: January 2016 If you would like this document
More informationHow To Be A Senior Pharmacy Technician
JOB DESCRIPTION JOB TITLE : Senior Pharmacy Technician DEPARTMENT : Pharmacy Heartlands, Solihull & Good Hope Hospitals GRADE : Band 5 HOURS OF DUTY : 37.5 hours per week. The Trust operates a 7 day working
More informationLocal Enhanced Service Specification for the Supply of Pharmaceutical Services to Care Homes through Community Pharmacy
Local Enhanced Service Specification for the Supply of Pharmaceutical Services to Care Homes through Community Pharmacy Contents: 1. Introduction and purpose 2. Period of Service 3. Aim of the Service
More informationADMINISTRATION OF MEDICATION
ADMINISTRATION OF MEDICATION IN SCHOOLS MARYLAND STATE SCHOOL HEALTH SERVICES GUIDELINE JANUARY 2006 (Reference Updated March 2015) Maryland State Department of Education Maryland Department of Health
More informationMedication Administration Procedure
Medication Administration Procedure Procedure Name Medication Administration Approved by Category Work Practice Approval date April 2014 Version 1 Review date April 2016 Why do we need this procedure?
More informationProfessional Standards and Guidance for the Sale and Supply of Medicines
Professional Standards and Guidance for the Sale and Supply of Medicines About this document The Code of Ethics sets out seven principles of ethical practice that you must follow as a pharmacist or pharmacy
More informationA safe return and reuse protocol in the community pharmacy setting may include, but is not limited to, the following elements:
National Association of Boards of Pharmacy Position Statement on the Return and Reuse of Prescription Medications in the Community Pharmacy Setting July 2009 The National Association of Boards of Pharmacy
More informationMemorandum of Understanding. between. Tasmania Police and Tasmanian Schools and Colleges
Memorandum of Understanding between Tasmania Police and Tasmanian Schools and Colleges GUIDELINES FOR MANAGING DRUG-RELATED INCIDENTS IN TASMANIAN SCHOOLS 2015-2019 Guidelines for managing drug related
More informationOPERATIONS POLICY AND PROCEDURE
INTRODUCTION The San Ramon Valley Fire Protection District provides both First Responder Advanced Life Support (ALS) on the fire apparatus and ALS Ambulance transport. As an ALS provider, the District
More informationTameside Metropolitan Borough Council ICT Security Policy for Schools. Adopted by:
Tameside Metropolitan Borough Council ICT Security Policy for Schools Adopted by: 1. Introduction 1.1. The purpose of the Policy is to protect the institution s information assets from all threats, whether
More informationQUALIFICATION DETAILS
QUALIFICATION DETAILS Qualification Title New Zealand Certificate in Pharmacy (Pharmacy Technician) (Level 4) Version 1 Qualification type Certificate Level 4 Credits 75 NZSCED DAS Classification Strategic
More informationMethadone Maintenance Treatment for Opioid Dependence
COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO P O L I C Y S TAT E M E N T # 2 1 0 Methadone Maintenance Treatment for Opioid Dependence APPROVED BY COUNCIL: PUBLICATION DATE: KEY WORDS: REFERENCE MATERIALS:
More informationSTANDARD OPERATING PROCEDURE #401 CONTROLLED SUBSTANCES
STANDARD OERATING ROCEDURE #401 CONTROLLED SUBSTANCES 1. UROSE This Standard Operating rocedure (SO) describes procedures for acquiring, storing, using and discarding controlled substances. 2. RESONSIBILITY
More informationStandards for medicines management Guidance for nurses and midwives
Record keeping Standards for medicines management Guidance for nurses and midwives 1 15105_Record Keeping_A5_proof 3.indd 1 09/03/2010 09:47 We are the nursing and midwifery regulator for England, Wales,
More information8. To ensure the accurate use of all pharmacy computer systems and to record all issues, receipts and returns of medicines.
JOB DESCRIPTION JOB TITLE PAY BAND DIRECTORATE / DIVISION DEPARTMENT BASE RESPONSIBLE TO ACCOUNTABLE TO RESPONSIBLE FOR Student Pharmacy Technician Band 4 (1st year 70% of top point on band 4, 2 nd year
More informationFebruary 19, 2013. Dear Ms. Leonhart:
Ms. Michele M. Leonhart Administrator Drug Enforcement Administration U.S. Department of Justice 8701 Morrissette Drive Springfield, VA 22152 Re: Notice of proposed rulemaking on Disposal of Controlled
More informationCHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)
CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) Section 61-03-02-01 Definitions 61-03-02-02 Absence of Provider or Consulting Pharmacist
More informationA BILL for AN ACT. Serial 270 Volatile Substance Abuse Prevention Bill 2004 Ms Scrymgour
Serial 270 Volatile Substance Abuse Prevention Bill 2004 Ms Scrymgour A BILL for AN ACT to provide for the prevention of volatile substance abuse and the protection of individuals and communities from
More informationPrescribing Controlled Drugs in Addiction Treatment. Section 24 Misuse of Drugs Act 1975
Prescribing Controlled Drugs in Addiction Treatment Section 24 Misuse of Drugs Act 1975 Citation: Ministry of Health. 2013. Prescribing Controlled Drugs in Addiction Treatment: Section 24 Misuse of Drugs
More information11/30/2015 DAYMARK RECOVERY SERVICES PROCEDURES. Procedure #: 2210 Page: 1 of 3
Section 2 General Program Standards; E. Medication Procedure Consumer of Medications and Medical Services Effective 7/03/14 Review By: 7/03/15 Procedure #: 6040 Consumer of Medications and Medical Services
More informationBOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS
BOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS 855-041-6050 Definitions Hospitals with Pharmacies (1) In
More informationQuestions and answers for custodians about the Personal Health Information Privacy and Access Act (PHIPAA)
Questions and answers for custodians about the Personal Health Information Privacy and Access Act (PHIPAA) This document provides answers to some frequently asked questions about the The Personal Health
More informationRequirements for the prescribing of Schedule 4 and Schedule 8 Medicines in Western Australia
Requirements for the prescribing of Schedule 4 and Schedule 8 Medicines in Western Australia Pharmaceutical Services Branch June 2008 1 Key Points Prescribing Schedule 4 medicines (S4s) S4 prescriptions
More informationNOTE: In the event that the seal is accidentally broken, the narcotic may be wasted via narcotic wastage procedures.
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER NARCOTICS AND CONTROLLED DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
More informationControlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY
2015 Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY Contents A. Controlled Substance Policy... 4 1. Background, Purpose, and Scope...
More informationGuidance to Nurses and Midwives on Medication Management JULY 2007
Guidance to Nurses and Midwives on Medication Management JULY 2007 Guidance to Nurses and Midwives on Medication Management July 2007 supersedes Guidance to Nurses and Midwives on Medication Management
More informationMedical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
More informationALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS
ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS 610-X-5-.01 610-X-5-.02 610-X-5-.03 610-X-5-.04 610-X-5-.05 610-X-5-.06 610-X-5-.07
More informationSAFE HANDLING AND ADMINISTRATION OF MEDICINES POLICY
SAFE HANDLING AND ADMINISTRATION OF MEDICINES POLICY Issue History Issue Version Purpose of Issue/Description of Change April 2007 Third Issue Planned update incorporating new national guidance Planned
More informationPrescribers required to check PDMP before first prescription for Controled Substances for new patient.
State, District, or Territory Alabama Arizona Arkansas Colorado Connecticut Delaware Georgia Guam Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate,
More informationNurse-Managed Medication Inventory
Nurse-Managed Medication Inventory Information for Employers College of Registered Nurses of British Columbia 2855 Arbutus Street Vancouver, BC Canada V6J 3Y8 T: 604.736.7331 F: 604.738.2272 Toll-free:
More informationCOLORADO MEDICAL BOARD RULES AND REGULATIONS FOR LICENSURE OF AND PRACTICE BY PHYSICIAN ASSISTANTS (PAs) INTRODUCTION
Rule 400 3 CCR 713-7 COLORADO MEDICAL BOARD RULES AND REGULATIONS FOR LICENSURE OF AND PRACTICE BY PHYSICIAN ASSISTANTS (PAs) INTRODUCTION BASIS. The authority for promulgation of Rule 400 ( these Rules
More information2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
More informationAdopted Rule - 11/19/14 1
Adopted Rule - 11/19/14 1 CHAPTER Ph 800 PHARMACY TECHNICIANS Statutory Authority: RSA 318:5-a, X, XI Adopt Ph 801 & Ph 802, previously effective 7-25-01 (Doc. # 7535) and expired on 7-25-09, to read as
More informationCh. 109 NURSING SERVICES 28 CHAPTER 109. NURSING SERVICES GENERAL PROVISIONS
Ch. 109 NURSING SERVICES 28 CHAPTER 109. NURSING SERVICES GENERAL PROVISIONS Sec. 109.1. Principle. 109.2. Director of nursing services. 109.3. Assistants to director of nursing services. 109.4. Professional
More informationPursuant to the authority vested in the Commissioner of Health by Article 33 of the
Electronic Prescriptions and Records for Hypodermic Needles and Hypodermic Syringes Effective date: 10/9/13 Pursuant to the authority vested in the Commissioner of Health by Article 33 of the Public Health
More informationDEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS
DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS (By authority conferred on the director of the department of licensing and
More informationCOLORADO MEDICAL BOARD RULES AND REGULATIONS FOR LICENSURE OF AND PRACTICE BY PHYSICIAN ASSISTANTS
Rule 400 3 CCR 713-7 COLORADO MEDICAL BOARD RULES AND REGULATIONS FOR LICENSURE OF AND PRACTICE BY PHYSICIAN ASSISTANTS BASIS. The authority for promulgation of Rule 400 ( these Rules ) by the Colorado
More informationThe practice of medicine comprises prevention, diagnosis and treatment of disease.
English for Medical Students aktualizované texty o systému zdravotnictví ve Velké Británii MUDr Sylva Dolenská Lesson 16 Hospital Care The practice of medicine comprises prevention, diagnosis and treatment
More informationHeadin. The Disposal of Medicines in. Nursing Homes. A Guide to Good Practice
Headin The Disposal of Medicines in g Nursing Homes A Guide to Good Practice Place your message here. For maximum impact, use two or three sentences. November 2011 Contents Page 1.0 Introduction 3 2.0
More informationMedicines Administration and Management Policy for Reg Nurses, Midwives and SCPHNs
This is an official Northern Trust policy and should not be edited in any way Medicines Administration and Management Policy for Reg Nurses, Midwives and SCPHNs Reference Number: NHSCT/10/294 Target audience:
More informationMEDICINE MANAGEMENT POLICY
MEDICINE MANAGEMENT POLICY NWAS Medicine Management Policy Page: Page 1 of 43 Approved by Quality Committee Approval date January 2014 Version number 3.0 Review date January 2016 Responsible Director Responsible
More informationHow To Administer Medication In West Virginia
WOOD COUNTY BOARD OF EDUCATION Last Reviewed: July 18, 2006 Policy 5140 Medication Administration Next Review: July 18, 2008 I. Purpose A. Good health and safety are essential to student learning. The
More informationSAFER MANAGEMENT OF CONTROLLED DRUGS Report to the Clinical Governance Committee 8 th October 2014
SAFER MANAGEMENT OF CONTROLLED DRUGS Report to the Clinical Governance Committee 8 th October 2014 1. PURPOSE OF REPORT AND PERIOD COVERED BY REPORT 1.1. The purpose of this report is to update the Committee
More informationTHE SAFE AND SECURE A TEAM APPROACH HANDLING OF MEDICINES: March 2005
March 2005 THE SAFE AND SECURE HANDLING OF MEDICINES: A TEAM APPROACH A revision of the Duthie Report (1988) led by the Hospital Pharmacists Group of the Royal Pharmaceutical Society Preface A prescribed
More informationNEBRASKA HEALTH AND HUMAN SERVICES SYSTEM
2007 STATE OF NEBRASKA TITLE 181 CHAPTER 6 Cancer Drug Repository Program NEBRASKA HEALTH AND HUMAN SERVICES SYSTEM Department of Health and Human Services Regulation and Licensure Credentialing Division
More informationNH Laws / Rules Regarding Limited Retail Drug Distributors
NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant
More information02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE
More informationGood Practice Guidance: The administration of medicines in domiciliary care
Good Practice Guidance: The administration of medicines in domiciliary care Medicines Management Social Care Support Team Reviewed February 2014 This guidance is based on documents that were on CQC s website
More informationCHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS
I. INTRODUCTION CHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS Advance registered nurse practitioners (ARNPs) and clinical nurse practitioners (CNPs) have their scope
More informationJOB DESCRIPTION. Clinical Nurse Manager 2 (CNM2) Staff Nurses, Health Care Assistants, Administration staff, Student Nurses and all hospital staff.
Job Title: JOB DESCRIPTION Clinical Nurse Manager 2 (CNM2) Professionally accountable to: Key working relationships: Key Reporting relationship: Director of Nursing Clinical Nurse Managers, Medical Staff,
More informationHIGHLY SPECIALISED DRUGS PROGRAM AND HERCEPTIN PROGRAM. Western Australia Administrative Guidelines
HIGHLY SPECIALISED DRUGS PROGRAM AND HERCEPTIN PROGRAM Western Australia Administrative Guidelines Pharmaceutical Services Branch Health Protection Group Table of Contents BACKGROUND...1 Overview...1 AHMAC
More information105 CMR: DEPARTMENT OF PUBLIC HEALTH 105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS
105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS Section 210.001: Purpose 210.002: Definitions 210.003: Policies Governing the Administration of Prescription
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationSECTION 18 1 FRAUD, WASTE AND ABUSE
SECTION 18 1 FRAUD, WASTE AND ABUSE Annual FW&A Training Required for Providers and Office Staff 1 Examples of Fraud, Waste and Abuse 2 Fraud, Waste and Abuse Program Policy 3 Suspected Non-Compliance
More informationMID CHESHIRE HOSPITALS NHS FOUNDATION TRUST PHARMACEUTICAL SERVICES JOB DESCRIPTION. 75% Top Band 4 2 nd year Pharmacy Department, Leighton Hospital
MID CHESHIRE HOSPITALS NHS FOUNDATION TRUST PHARMACEUTICAL SERVICES JOB DESCRIPTION POST: BAND: LOCATION: RESPONSIBLE TO: MANAGED BY: TRAINEE PHARMACY TECHNICIAN 70% Top Band 4 1 st year 75% Top Band 4
More informationDrugs of Dependence Unit Telephone 1300 652 584 Facsimile 1300 658 447 Issued: 13 July 2010 Updated: 1 February 2012
Drugs of Dependence Unit Telephone 1300 652 584 Facsimile 1300 658 447 Issued: 13 July 2010 Updated: 1 February 2012 Guidelines for action to be taken in response to serious breaches of the drug treatment
More informationImmunisation Services - Authority for Registered Nurses and Midwives
Policy Directive Ministry of Health, NSW 73 Miller Street North Sydney NSW 2060 Locked Mail Bag 961 North Sydney NSW 2059 Telephone (02) 9391 9000 Fax (02) 9391 9101 http://www.health.nsw.gov.au/policies/
More information16.19.10.11 PUBLIC HEALTH CLINICS: A. CLINIC LICENSURE: (1) All clinics where dangerous drugs are administered, distributed or dispensed shall obtain
16.19.10.11 PUBLIC HEALTH CLINICS: A. CLINIC LICENSURE: (1) All clinics where dangerous drugs are administered, distributed or dispensed shall obtain a limited drug permit as described in Section 61-11-14
More informationMedical Malpractice Insurance Policy
Proposal Form Medical Malpractice Insurance Policy ADNIC is a Public Joint Stock Company incorporated in the United Arab Emirates by Law No. (4) of 1972, and it is governed by the provisions of the UAE
More informationJOB DESCRIPTION. JOB TITLE & BAND: Lead Pharmacy Technician, Education & Training -Band 5. Pharmacy Department, Altnagelvin Hospital
JOB DESCRIPTION JOB TITLE & BAND: Lead Pharmacy Technician, Education & Training -Band 5 DEPARTMENT: BASE: REPORTS TO: RESPONSIBLE TO: Pharmacy Pharmacy Department, Altnagelvin Hospital Teacher Practitioner
More informationManagement of Medication Policy within Residential Child Care Establishments across Forth Valley
Management of Medication Policy within Residential Child Care Establishments across Forth Valley Date of First Issue 01/11/2008 Approved 01/11/2008 Current Issue Date 09/09/2013 Review Date 09/09/2016
More information